Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sandberg

Showing results (311-320 of 348) with videos related to

Pageof 35
Sort By:
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Journal of Hepatology|May 18, 2019
Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cellsJoana Dias, Julia Hengst, Tiphaine Parrot, et al.
Plos Biology|June 9, 2020
Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coliCaroline Boulouis, Wan Rong Sia, Muhammad Yaaseen Gulam, et al.
ACS Chemical Neuroscience|November 7, 2024
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein DepletionWanda Christ, Sebastian Kapell, Michal J Sobkowiak, et al.
The Journal of Infectious Diseases|November 19, 2014
HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsMichael A Eller, Marc S Opollo, Michelle Liu, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Open Biology|December 4, 2015
A systematic investigation of production of synthetic prions from recombinant prion proteinChristian Schmidt, Jeremie Fizet, Francesca Properzi, et al.
Science Immunology|September 29, 2020
MAIT cell activation and dynamics associated with COVID-19 disease severityTiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, et al.
Science Immunology|July 5, 2020
TOX is expressed by exhausted and polyfunctional human effector memory CD8<sup>+</sup> T cellsTakuya Sekine, André Perez-Potti, Son Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533David B Dix, Geetika Khanna, Lindsay A Renfro, et al.
Pageof 35

Showing results (311-320 of 348) with videos related to

Sort By:
Pageof 35
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Journal of Hepatology|May 18, 2019
Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cellsJoana Dias, Julia Hengst, Tiphaine Parrot, et al.
Plos Biology|June 9, 2020
Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coliCaroline Boulouis, Wan Rong Sia, Muhammad Yaaseen Gulam, et al.
ACS Chemical Neuroscience|November 7, 2024
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein DepletionWanda Christ, Sebastian Kapell, Michal J Sobkowiak, et al.
The Journal of Infectious Diseases|November 19, 2014
HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsMichael A Eller, Marc S Opollo, Michelle Liu, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Open Biology|December 4, 2015
A systematic investigation of production of synthetic prions from recombinant prion proteinChristian Schmidt, Jeremie Fizet, Francesca Properzi, et al.
Science Immunology|September 29, 2020
MAIT cell activation and dynamics associated with COVID-19 disease severityTiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, et al.
Science Immunology|July 5, 2020
TOX is expressed by exhausted and polyfunctional human effector memory CD8<sup>+</sup> T cellsTakuya Sekine, André Perez-Potti, Son Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533David B Dix, Geetika Khanna, Lindsay A Renfro, et al.
Pageof 35